Fourth Contrast Study: contrast study for patients undergoing diagnostic coronary angiography
Not Applicable
Completed
- Conditions
- AngiographySurgery
- Registration Number
- ISRCTN16544658
- Lead Sponsor
- Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
1. Patients admitted for cardiac catheterisation.
2. Approximately 2000 subjects.
3. No selection bias to gender or age group.
Exclusion Criteria
Pregnant patients will be excluded, unless patient has life threatening condition.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical outcome and adverse effects of the contrast agents.
- Secondary Outcome Measures
Name Time Method ot provided at time of registration
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie contrast agent efficacy in coronary angiography as studied in ISRCTN16544658?
How does ISRCTN16544658 compare iodinated contrast agents with newer non-iodinated alternatives in coronary angiography outcomes?
What biomarkers are associated with contrast-induced nephropathy risk in patients undergoing coronary angiography per ISRCTN16544658?
What adverse events were observed in ISRCTN16544658 using high-osmolar versus low-osmolar contrast media for coronary angiography?
How do combination approaches of contrast agents with antiplatelet therapies impact procedural success in ISRCTN16544658 coronary angiography study?